|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacodynamic, phar- macokinetic and tolerability evaluation of concomitant administra- tion of lesinurad and febuxostat in gout patients with hyperuricae-mia 显示文摘 | Fleischmann R Kerr B Yeh LT | 2014 | Rheumatology2014，53，12： | 1 |
| 2 | Mode of action of RDEA594 as a uric acid lowering agent in humans following multiple doses of its pro-drug RDEA806 显示文摘 | Yeh LT Sato M Tamai I | 2008 | Ann Rheum Dis2008，67，： | 1 |
| 3 | A sensitive and specific method for the determination of total ribavirin in monkey liver by high-performance liquid chromatography with tandem mass spectrometry显示文摘 | YEH LT NGUYEN M LOURENCO D | 2005 | J Pharm Biomed Anal2005，38，1： | 1 |
| 4 | High signal intensity rim surrounding utedne leiomyomas on MR images:pathologic correlation显示文摘 | Mittle RL Yeh LT Kresse HY | 1991 | Radiology1991，180，： | 1 |
| 5 | Nuclear expression of BCL10ornuclear factor kappa B predicts Helicobacter pylori-independent statusof early-stage,high-grade gastric mucosa-associated lymphoid tissuelymphomas显示文摘 | Kuo SH Chen LT Yeh KH | 2004 | J Clin Oncol2004，22，17： | 1 |
| 6 | Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease显示文摘 | Yeh CC Sung FC Kuo LT | 2009 | Murat Res2009，667，12： | 1 |
| 7 | Nuclear expression of BCL10ornuclear factor kappa B helps predict Helicobacter pylori-independentstatus of low-grade gastric mucosa-associated lymphoid tissue lym-phomas with or without t(11;18)(q21;q21)显示文摘 | Yeh KH Kuo SH Chen LT | 2005 | Blood2005，106，3： | 1 |
| 8 | B lymphocyte-induces maturation pro- tein 1 (BLIMP-1)attenuates autoimmune diabetes in NOD mice bysup- pressing Thl and Thl7 cells显示文摘 | Lin MH Chou FC Yeh LT | 2013 | Diabetologia2013，56，1： | 1 |
| 9 | T ceU-specific BLIMP-I deficiency exacerbates experimental autoirmntme encephalomyelitis in nonobese diabetic mice by increasing Thl and Thl7 cells显示文摘 | Lin MH Yeh LT Chen SJ | 2014 | Clin Immunol2014，151，2： | 1 |
| 10 | Helicobacter pylori - related diffuselarge B - cell lymphoma of the stomach : a distinct entity with lower ag- gressiveness and higher chemosensitivity显示文摘 | Kuo SH Yeh KH Chen LT | 2014 | Blood Cancer J2014，4，3： | 1 |
| 11 | Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of ad- vanced gastric cancers:an effective and low-toxic regimen for pa- tients with poor general condition 显示文摘 | Hsu CH Yeh KH Chen LT | 1997 | Oncology1997，54，4： | 1 |
| 12 | Specific, sensitive and accurate liquid chromatographic tadem mass spectrometric method for the measurement of ribavirin in rat and monkey plasma 显示文摘 | Lin CC Yeh LT Lau JY | 2002 | J Chromatogr B Analyt Technol Biomed Life Sci2002，779，2： | 1 |
| 13 | LC-MS/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells显示文摘 | Yeh LT Nguyen M Dadgostari S | 2007 | J Pharm Biomed Anal2007，43，3： | 1 |
| 14 | Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys显示文摘 | Lin CC Yeh LT VitareUa D | 2004 | Antivir Chem Chemother2004，15，6： | 1 |
| 15 | Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori- independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t ( 11 ; 18) ( q21 ; q21 ) 显示文摘 | Yeh KH Kuo SH Chen LT | 2005 | Blood2005，106，3： | 1 |
| 16 | Specific, sensitive and accurate liquid chromatographic-tadem mass spectrometric method for the measurement of ribavirin in rat and monkey plasma显示文摘 | Lin CC Yeh LT Lau JY | 2002 | J Chromatogr B Analyt Technol Biomed Life Sci2002，779，2： | 1 |
| 17 | Pharmacodynam- ic, pharmacokinetic and tolerability evaluation of concomi- tant administration of lesinurad and febuxostat in gout pa- tients with hyperuricaemia显示文摘 | Fleischmann R Kerr B Yeh LT | 2014 | Rheumatology(Oxford)2014，53，12： | 1 |
| 18 | Concurrent chemoradiotherapy for locally advanced esophageal cancer-a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil显示文摘 | Yeh KH lui LT | 1999 | Anticancer Res1999，19，5： | 1 |
| 19 | Lesinurad (DEA594),a novel uricosuric agent,in combination with febuxostat shows significant additive urate- lowering effects in gout patients with 100% response achieved for all combination dose regimens 显示文摘 | Fleishmann R Shen Z Yeh LT | 2011 | Ann Rheum Dis2011，70，3： | 1 |
| 20 | Lesinurad(RDEA594),a novel oral uricosuric agent,in combination with febuxostat shows significantadditive urate lowering effects in gout patients with 100%response achieved for all combination dose regimens显示文摘 | Fleischmann R Shen Z Yeh LT | 2011 | Ann Rheum Dis2011，63，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员